Cover Image

A randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in Emergency Department, HUSM

This study is done to evaluate the effectiveness of symbicort (a combination of formoterol and budesonide) as an alternative reliever in mild to moderate acute axacerbation of bronchial asthma Patients who fulfilled the criteria of mild or moderate asthmatic attack and agreed to participate in th...

Full description

Saved in:
Bibliographic Details
Main Author: Chew Keng, Sheng
Format: Monograph
Language:English
Published: Pusat Pengajian Sains Perubatan 2012
Subjects:
R Medicine (General)
Online Access:http://eprints.usm.my/55395/1/DR.%20CHEW%20KENG%20SHENG%20-%20e.pdf
http://eprints.usm.my/55395/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.usm.eprints.55395
record_format eprints
spelling my.usm.eprints.55395 http://eprints.usm.my/55395/ A randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in Emergency Department, HUSM Chew Keng, Sheng R Medicine (General) This study is done to evaluate the effectiveness of symbicort (a combination of formoterol and budesonide) as an alternative reliever in mild to moderate acute axacerbation of bronchial asthma Patients who fulfilled the criteria of mild or moderate asthmatic attack and agreed to participate in this study were randomly assigned to either nebulized salbutamol or symbicort turbuhaler as the treatment. Objective and clinical parameters such as respiratory mte (RR), oxygen saturation (SP02), peak expiratory flow mte (PEFR) and fraction of exhale nitric oxide (FENO) were recorded before and after treatment. Subjective assessment using visual analog score and 5-point Likert scale were also taken. The patients were reassessed 15 minutes later for need of further treatment After randomization, 17 out of 32 patients were chosen to receive nebulized salbutamol and another 15 patients to receive symbicort. There were significant improvements in respiratory mte (RR), oxygen satumtion (SP02) and PEFR in patients received symbicort turbuhler (p=O.OOI, p=0.027 and p=<O.OOJ respectively). This result is significant in patients receiving nebulized salbutamol as well. When compared between these two groups, no significant difference was demonstmted. In terms of subjective parameters using 'Visual Analog Score' and '5-point Likert Scale' of breathlessness, it also showed that there were no significant difference in patients who received symbicort turbuhaler or nebulized salbutamol. Symbicort has the potential to be used as an alternative treatment for patients with mild to moderate exacerbation of asthma as there were no significant difference in terms of objective and subjective improvements at least for the first 15 minutes. Pusat Pengajian Sains Perubatan 2012 Monograph NonPeerReviewed application/pdf en http://eprints.usm.my/55395/1/DR.%20CHEW%20KENG%20SHENG%20-%20e.pdf Chew Keng, Sheng (2012) A randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in Emergency Department, HUSM. Other. Pusat Pengajian Sains Perubatan. (Submitted)
institution Universiti Sains Malaysia
building Hamzah Sendut Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Sains Malaysia
content_source USM Institutional Repository
url_provider http://eprints.usm.my/
language English
topic R Medicine (General)
spellingShingle R Medicine (General)
Chew Keng, Sheng
A randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in Emergency Department, HUSM
description This study is done to evaluate the effectiveness of symbicort (a combination of formoterol and budesonide) as an alternative reliever in mild to moderate acute axacerbation of bronchial asthma Patients who fulfilled the criteria of mild or moderate asthmatic attack and agreed to participate in this study were randomly assigned to either nebulized salbutamol or symbicort turbuhaler as the treatment. Objective and clinical parameters such as respiratory mte (RR), oxygen saturation (SP02), peak expiratory flow mte (PEFR) and fraction of exhale nitric oxide (FENO) were recorded before and after treatment. Subjective assessment using visual analog score and 5-point Likert scale were also taken. The patients were reassessed 15 minutes later for need of further treatment After randomization, 17 out of 32 patients were chosen to receive nebulized salbutamol and another 15 patients to receive symbicort. There were significant improvements in respiratory mte (RR), oxygen satumtion (SP02) and PEFR in patients received symbicort turbuhler (p=O.OOI, p=0.027 and p=<O.OOJ respectively). This result is significant in patients receiving nebulized salbutamol as well. When compared between these two groups, no significant difference was demonstmted. In terms of subjective parameters using 'Visual Analog Score' and '5-point Likert Scale' of breathlessness, it also showed that there were no significant difference in patients who received symbicort turbuhaler or nebulized salbutamol. Symbicort has the potential to be used as an alternative treatment for patients with mild to moderate exacerbation of asthma as there were no significant difference in terms of objective and subjective improvements at least for the first 15 minutes.
format Monograph
author Chew Keng, Sheng
author_facet Chew Keng, Sheng
author_sort Chew Keng, Sheng
title A randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in Emergency Department, HUSM
title_short A randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in Emergency Department, HUSM
title_full A randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in Emergency Department, HUSM
title_fullStr A randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in Emergency Department, HUSM
title_full_unstemmed A randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in Emergency Department, HUSM
title_sort randomized controlled trial on the use of budesonide/formoterol (symbicort) as an alternative reliever medication for mild to moderate asthmatic attack in adult patients in emergency department, husm
publisher Pusat Pengajian Sains Perubatan
publishDate 2012
url http://eprints.usm.my/55395/1/DR.%20CHEW%20KENG%20SHENG%20-%20e.pdf
http://eprints.usm.my/55395/
_version_ 1748181594022084608
score 13.211869

Similar Items